IN VITRO DIAGNOSTICS HistoRx Inc. Yale University HistoRx licenses new melanoma assay from Yale HistoRx Inc. (cancer diagnostics) has licensed a new prognostic melanoma assay from Yale Uni
by Beth Detuzzi Mergers & Acquisitions CareFusion Corp. & Medegen Inc. CareFusion Corp. , a September 2009 spin-off from Cardinal Health Inc. , is buying privately held device firm Medegen Inc.
New company creation slipped significantly in 2009 as venture capitalists conserved capital and supported existing portfolio companies. In biopharmaceuticals, corporate venture got in at the ground fl